These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 88522)

  • 1. Pyranenamines: a new series of antiallergic compounds.
    Snader KM; Chakrin LW; Cramer RD; Gelernt YM; Miao CK; Shah DH; Venslavsky JW; Willis CR; Sutton BM
    J Med Chem; 1979 Jun; 22(6):706-14. PubMed ID: 88522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic characterization of the antiallergic activity of SK&F 78729-A.
    Chakrin LW; Krell RD
    J Pharmacol Exp Ther; 1978 Dec; 207(3):756-66. PubMed ID: 83359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
    Loev B; Musser JH; Brown RE; Jones H; Kahen R; Huang FC; Khandwala A; Sonnino-Goldman P; Leibowitz MJ
    J Med Chem; 1985 Mar; 28(3):363-6. PubMed ID: 2579236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen bridgehead compounds. 18. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 1.
    Hermecz I; Breining T; Mészáros Z; Horváth A; Vasvári-Debreczy L; Dessy F; DeVos C; Rodriguez L
    J Med Chem; 1982 Oct; 25(10):1140-5. PubMed ID: 6183427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites].
    Hashimoto T; Edanami K; Naito A; Sano K; Fushimi H; Goto M
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):159-66. PubMed ID: 1695192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.
    Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P
    J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antiallergic agents. Part I: Synthesis and pharmacology of pyrimidine amide derivatives.
    Ban M; Taguchi H; Katsushima T; Aoki S; Watanabe A
    Bioorg Med Chem; 1998 Jul; 6(7):1057-67. PubMed ID: 9730243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnoline-3-propionic acids, a new series of orally active antiallergic substances.
    Holland D; Jones G; Marshall PW; Tringham GD
    J Med Chem; 1976 Oct; 19(10):1225-8. PubMed ID: 825646
    [No Abstract]   [Full Text] [Related]  

  • 10. [1,4]Benzoxazine-2,3-diones as antiallergic agents.
    Loev B; Jones H; Brown RE; Huang FC; Khandwala A; Leibowitz MJ; Sonnino-Goldman P
    J Med Chem; 1985 Jan; 28(1):24-7. PubMed ID: 2578192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on type I allergic reactions.
    Kohno SW; Murata T; Kinoshita T; Ohata K
    Arzneimittelforschung; 1986 Nov; 36(11):1619-27. PubMed ID: 2434110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and quantitative structure-activity relationships of antiallergic 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides.
    Ford RE; Knowles P; Lunt E; Marshall SM; Penrose AJ; Ramsden CA; Summers AJ; Walker JL; Wright DE
    J Med Chem; 1986 Apr; 29(4):538-49. PubMed ID: 2870188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallergic activity of 6-(2-cyclohexylethyl)-[1,3,4]thiadiazolo- [3,2-a]-1,2,3-triazolo-[4,5-d]pyrimidin-9(3H)-one (DS-4574) in rats.
    Aibara S; Mori M; Tsubokawa M; Iwamoto T; Tsukada W
    Int Arch Allergy Immunol; 1992; 98(2):146-52. PubMed ID: 1379506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced modifications of the immune response. 1. Substituted 1-phenylisoquinolines.
    St Georgiev V; Carlson RP; Van Inwegen RG; Khandwala A
    J Med Chem; 1979 Apr; 22(4):348-52. PubMed ID: 85712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ro 21-7634, a new antiallergic agent with potent oral activity.
    Salvador RA; Czyzewski LB; Baruth H; Hooper A; Medford A; Miller D; van Trabert T; Yaremko B; Welton AF
    Agents Actions; 1981 Jul; 11(4):339-44. PubMed ID: 7025596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on antianaphylactic agents. 7. Synthesis of antiallergic 5-oxo-5H-[1]benzopyrano[2,3-b]pyridines.
    Nohara A; Ishiguro T; Ukawa K; Sugihara H; Maki Y; Sanno Y
    J Med Chem; 1985 May; 28(5):559-68. PubMed ID: 3989816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
    Siminoff P; Reed FC; Schurig JE; Juby PF
    Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.